Mamilos, A.; Winter, L.; Lein, A.; Spoerl, S.; Ludwig, N.; Ettl, T.; Künzel, J.; Reichert, T.; Spanier, G.; Brochhausen, C.
Metformin Treatment Is Not Associated with Altered PD-L1 Expression in Diabetic Patients with Oral Squamous Cell Carcinoma. J. Clin. Med. 2024, 13, 5632.
https://doi.org/10.3390/jcm13185632
AMA Style
Mamilos A, Winter L, Lein A, Spoerl S, Ludwig N, Ettl T, Künzel J, Reichert T, Spanier G, Brochhausen C.
Metformin Treatment Is Not Associated with Altered PD-L1 Expression in Diabetic Patients with Oral Squamous Cell Carcinoma. Journal of Clinical Medicine. 2024; 13(18):5632.
https://doi.org/10.3390/jcm13185632
Chicago/Turabian Style
Mamilos, Andreas, Lina Winter, Alexander Lein, Steffen Spoerl, Nils Ludwig, Tobias Ettl, Julian Künzel, Torsten Reichert, Gerrit Spanier, and Christoph Brochhausen.
2024. "Metformin Treatment Is Not Associated with Altered PD-L1 Expression in Diabetic Patients with Oral Squamous Cell Carcinoma" Journal of Clinical Medicine 13, no. 18: 5632.
https://doi.org/10.3390/jcm13185632
APA Style
Mamilos, A., Winter, L., Lein, A., Spoerl, S., Ludwig, N., Ettl, T., Künzel, J., Reichert, T., Spanier, G., & Brochhausen, C.
(2024). Metformin Treatment Is Not Associated with Altered PD-L1 Expression in Diabetic Patients with Oral Squamous Cell Carcinoma. Journal of Clinical Medicine, 13(18), 5632.
https://doi.org/10.3390/jcm13185632
